50% off Premium Yearly

NASDAQ:NUTX
This summary was created by AI, based on 2 opinions in the last 12 months.
Nutex Health Inc. (NUTX-Q) has been reviewed by Stockchase Research Editor Michael O'Reilly, who notes both the positive growth prospects and recent performance issues. The company operates 27 micro-hospitals across 12 U.S. states and is anticipated to experience significant annual EPS growth exceeding 30% over the next five years. Despite a recent decline of 20.2%, O'Reilly highlights the stock’s attractive valuation metrics, trading at 8x earnings and 3.5x book value, with a robust return on equity of 63%. Cash reserves are increasing as the company pays down debt, providing a solid foundation for future growth. However, a stop-loss has been suggested at $126 due to recent performance, and there is an expected upside potential to $204, with analysts indicating a price target of $250.
Nutex Health Inc. is a American stock, trading under the symbol NUTX (previously NUTX-Q on Stockchase) on the NASDAQ (NUTX). It is usually referred to as NASDAQ:NUTX or NUTX
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on NUTX (previously NUTX-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Nutex Health Inc..
Nutex Health Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-01-27. Read the latest stock experts ratings for Nutex Health Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Nutex Health Inc..
Nutex Health Inc. is followed by 7 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-15, Nutex Health Inc. (NUTX) stock closed at a price of $147.07.
Our PAST TOP PICK with NUTX has triggered its stop at $126. To remain disciplined, we recommend covering the position at this time.